Kathryn E. Wengel - 10 Feb 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role: EVP, Chief TO and Risk Officer
Signature: Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol: JNJ
Transactions as of: 10 Feb 2023
Net transactions value: -$108,107
Form type: 4
Filing time: 14 Feb 2023, 15:37:04 UTC
Previous filing: 09 Feb 2023
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JNJ	Common Stock	Options Exercise	$0	+1,807	+2.5%	$0.000000	73,118	10 Feb 2023	Direct	F1
transaction	JNJ	Common Stock	Tax liability	$108,107	-667	-0.91%	$162.08	72,451	10 Feb 2023	Direct	F2
holding	JNJ	Common Stock						54	10 Feb 2023	By 401k	F3
holding	JNJ	Common Stock						281	10 Feb 2023	By ESOP	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JNJ	Restricted Share Units	Options Exercise	$0	-1,807	-100%	$0.000000^*	0	10 Feb 2023	Common Stock	1,807		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2	Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3	Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
F4	Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).